Central sensitization elicits pain hypersensitivity and is thought to be causally implicated in painful temporomandibular disorder (TMD). This causal inference is based on cross-sectional evidence that people with TMD have greater sensitivity than controls to noxious stimuli. We tested this inference in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) prospective cohort study of 3258 adults with no lifetime history of TMD when enrolled (visit 1). During 5 years of follow-up, 1 group labeled ''persistent TMD cases'' (n = 72) developed first-onset TMD by visit 2 that persisted P6 months until visit 3. Another group labeled ''transient TMD cases'' (n = 75) developed first-onset TMD at visit 2, which resolved by visit 3. Randomly sampled ''controls'' (n = 126) remained TMD-free throughout all 3 visits. At each visit, pressure pain thresholds (PPTs) were measured by algometry at 10 cranial and bodily sites. In persistent TMD case patients, mean PPTs reduced 43 kPa (P < .0001) between visits 1 and 2 and thereafter did not change significantly. In transient TMD case patients, mean PPTs reduced 41 kPa (P < .001) between visits 1 and 2, and then increased 20 kPa (P < .001) by visit 3. These patterns were similar after excluding cranial sites symptomatic for TMD. Importantly, visit 1 PPTs had no clinically useful prognostic value in predicting first-onset TMD (odds ratio [OR] = 1.07, P = .15). Among first-onset case patients, visit 2 PPTs were modest predictors of persistent TMD (OR = 1.36, P = .002). In this longitudinal study, PPTs reduced when TMD developed then rebounded when TMD resolved. However, premorbid PPTs poorly predicted TMD incidence, countering the hypothesis that PPTs signify mechanisms causing first-onset TMD. Ó
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Introduction
Pain thresholds vary markedly among people when blunt pressure is applied to their muscles and joints. Low-pressure pain thresholds (PPTs) may signify a generalized state of pain sensitivity, variously attributed to altered sensory processing, dysregulated endocrine function, hyperinflammatory states, or psychological processes [13] . There is strong support for a role of central sensitization, defined as ''amplification of neural signaling within the CNS that elicits pain hypersensitivity '' [31] . Central sensitization, in turn, is a putative cause of clinical pain syndromes including temporomandibular disorder (TMD) [31] . Hence, pressure algometers, which provide a simple and noninvasive method to assess PPTs, are recommended for clinical care and research with TMD patients [26] . 
